Calliditas is headquartered in Stockholm, Sweden.
Calliditas disclosed revenue of 1,207M SEK for 2023 and 803M SEK for 2022.
Calliditas has 222 employees.
Calliditas is a life science company.
Calliditas was founded in 2004.
Kungsbron 1, C8,
Stockholm,
111 22
Sweden,
+46 8 411 3005
www.calliditas.se
Calliditas is a specialty pharmaceutical company developing high-value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Calliditas was formed in 2004 and is based in Stockholm, Sweden.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $20M | $20M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Bryan Garnier & Co. |
1 |
| Legal | Deals |
|---|---|
|
Latham & Watkins |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
